Skip to main content
FutureChem Co., Ltd. logo

FutureChem Co., Ltd. — Investor Relations & Filings

Ticker · 220100 ISIN · KR7220100002 KO Manufacturing
Open in API
Filings indexed 312 across all filing types
Latest filing 2020-11-10 Report Publication Anno…
Country KR South Korea
Listing KO 220100

About FutureChem Co., Ltd.

https://www.futurechem.co.kr/?language=…

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Recent filings

Filing Released Lang Actions
[기재정정]기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a regulatory filing from FutureChem announcing the holding of an Investor Relations (IR) meeting. It provides details such as the date, location, purpose, and the method of the meeting (NDR). While it mentions IR materials, the document itself is a formal regulatory notice of the event, not the presentation deck itself. Therefore, it falls under the category of general regulatory announcements.
2020-11-10 Korean
기타경영사항(특허권취득)(자율공시)(전립선암 진단을 위한 18F-표지된 화합물 및 그의 용도)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from FutureChem regarding the acquisition of a patent for a prostate cancer diagnostic compound. It is filed as a 'voluntary disclosure' (자율공시) under the category of 'Other Management Matters' (기타 경영사항). Since it does not fit into specific categories like financial reports, board changes, or share transactions, it falls under the general regulatory filing category.
2020-11-09 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares issued, the conversion price, and the remaining balance of convertible bonds. This type of corporate action, involving the issuance of new shares resulting from debt conversion, falls under the category of capital changes or share issues.
2020-11-09 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from FutureChem regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares issued, the conversion price adjustment, and the impact on total shares outstanding. This type of filing relates to capital structure changes resulting from the conversion of debt into equity, which falls under the 'Share Issue/Capital Change' category.
2020-11-05 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by Susung Asset Management in the company FutureChem. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2020-11-03 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). It details the specific financial transaction where the company repurchased its own convertible bonds due to a put option exercise by bondholders. This type of corporate action regarding debt structure and capital changes falls under the 'Capital/Financing Update' category.
2020-09-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.